Bayer | BAYN - Sales Revenues


Bayer reported EUR13.41B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Air Liquide EUR 6.79B 6.43B Mar/2026
Akzo Nobel EUR 2.39B 20M Mar/2026
Alcon AG USD 2.69B 10M Mar/2026
Amarin USD 49.22M 451K Dec/2025
Arkema EUR 2.18B 70M Mar/2026
AstraZeneca USD 15.29B 213M Mar/2026
BASF EUR 16.02B 1.99B Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Beiersdorf EUR 2.48B 170M Mar/2026
Corteva USD 4.73B 820M Mar/2026
Covestro EUR 2.92B 255M Dec/2025
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.74B 140M Mar/2026
Fresenius Medical Care EUR 4.61B 460M Mar/2026
Genmab DKK 1.06B 36M Dec/2025
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
GRIFOLS EUR 1.7B 280M Mar/2026
Henkel EUR 10.09B 4.93B Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Johnson Matthey GBP 1.28B 0 Mar/2026
Linde USD 8.76B 149M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.13B 120M Mar/2026
Novartis USD 13.11B 226M Mar/2026
Nutrien USD 7.9B 870M Mar/2026
Philips EUR 3.91B 1.19B Mar/2026
PPG Industries USD 3.86B 50M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
SAP EUR 9.56B 120M Mar/2026
Solvay EUR 997M 2M Mar/2026
UCB EUR 4.25B 764M Dec/2025
Umicore EUR 10.68B 8.89B Dec/2025
Vinci EUR 16.28B 3.12B Dec/2025